{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:5551"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:5551","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Growth factors direct mesenchymal stem cell fate and therapeutic potential","abstract":"Murine mesenchymal stem cells (MSCs) isolated by plastic adherence contain contaminating cells and have poor growth and differentiation. I report a detailed protocol outlining the steps to prospectively isolate a pure and potent MSC population from murine bone marrow based on their expression of stem cell antigen-1 (Sca-1) and platelet derived growth factor- alpha (PDGFRα) (PαS cells) using flow cytometry. PαS MSCs have augmented growth potential and robust tri-lineage differentiation compared to plastic adherent cells. They exert potent immunosuppressive effects on proliferating naive CD4+ T cells, which is mediated via the production of nitric oxide (NO). Nevertheless, prolonged culture results in cellular senescence, loss of adipogenic differentiation and reduced immunosuppressive properties. Addition of growth factors to standard media (SM) produced significant genotypic and phenotypic changes. Cells cultured in SM supplemented with basic fibroblast growth factor (bFGF) and platelet derived growth factor-BB (PDGF-BB) were primed towards fat and cartilage, but had reduced immunosuppressive potential. In contrast, cells cultured with transforming growth factor-beta (TGF-β) had reduced tri-lineage potential but potent immunosuppressive properties that endured despite long term culture. I demonstrate using novel tissue engineering techniques that bFGF PαS MSCs generate substantial 3-D cartilage pellets. These data have implications for MSC therapy in humans.","abstract_html":"Murine mesenchymal stem cells (MSCs) isolated by plastic adherence contain contaminating cells and have poor growth and differentiation. I report a detailed protocol outlining the steps to prospectively isolate a pure and potent MSC population from murine bone marrow based on their expression of stem cell antigen-1 (Sca-1) and platelet derived growth factor- alpha (PDGFRα) (PαS cells) using flow cytometry. PαS MSCs have augmented growth potential and robust tri-lineage differentiation compared to plastic adherent cells. They exert potent immunosuppressive effects on proliferating naive CD4+ T cells, which is mediated via the production of nitric oxide (NO). Nevertheless, prolonged culture results in cellular senescence, loss of adipogenic differentiation and reduced immunosuppressive properties. Addition of growth factors to standard media (SM) produced significant genotypic and phenotypic changes. Cells cultured in SM supplemented with basic fibroblast growth factor (bFGF) and platelet derived growth factor-BB (PDGF-BB) were primed towards fat and cartilage, but had reduced immunosuppressive potential. In contrast, cells cultured with transforming growth factor-beta (TGF-β) had reduced tri-lineage potential but potent immunosuppressive properties that endured despite long term culture. I demonstrate using novel tissue engineering techniques that bFGF PαS MSCs generate substantial 3-D cartilage pellets. These data have implications for MSC therapy in humans.","abstract_has_math":false,"creators":["Houlihan, Diarmaid Dominic"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-07","date_published":"2015-07","updated_at":"2026-11-19T09:28:26Z","subjects":["R Medicine (General)","RC Internal medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/5551/1/Houlihan14PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A5551","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["mrc"]},{"key":"dc:creator","label":"Author","values":["Houlihan, Diarmaid Dominic"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-07"]},{"key":"dc:date.issued","label":"Date","values":["2015-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","School of Immunity and Infection"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/5551/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["R Medicine (General)","RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/5551/1/Houlihan14PhD.pdf","http://etheses.bham.ac.uk//id/eprint/5551/2/Decl_IS_Houlihan14PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Murine mesenchymal stem cells (MSCs) isolated by plastic adherence contain contaminating cells and have poor growth and differentiation. I report a detailed protocol outlining the steps to prospectively isolate a pure and potent MSC population from murine bone marrow based on their expression of stem cell antigen-1 (Sca-1) and platelet derived growth factor- alpha (PDGFRα) (PαS cells) using flow cytometry. PαS MSCs have augmented growth potential and robust tri-lineage differentiation compared to plastic adherent cells. They exert potent immunosuppressive effects on proliferating naive CD4+ T cells, which is mediated via the production of nitric oxide (NO). Nevertheless, prolonged culture results in cellular senescence, loss of adipogenic differentiation and reduced immunosuppressive properties. Addition of growth factors to standard media (SM) produced significant genotypic and phenotypic changes. Cells cultured in SM supplemented with basic fibroblast growth factor (bFGF) and platelet derived growth factor-BB (PDGF-BB) were primed towards fat and cartilage, but had reduced immunosuppressive potential. In contrast, cells cultured with transforming growth factor-beta (TGF-β) had reduced tri-lineage potential but potent immunosuppressive properties that endured despite long term culture. I demonstrate using novel tissue engineering techniques that bFGF PαS MSCs generate substantial 3-D cartilage pellets. These data have implications for MSC therapy in humans."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Growth factors direct mesenchymal stem cell fate and therapeutic potential"]}]}],"canonical_facts":{"dc:contributor.sponsor":["mrc"],"dc:creator":["Houlihan, Diarmaid Dominic"],"dc:date":["2015-07"],"dc:date.issued":["2015-07"],"dc:description.abstract":["Murine mesenchymal stem cells (MSCs) isolated by plastic adherence contain contaminating cells and have poor growth and differentiation. I report a detailed protocol outlining the steps to prospectively isolate a pure and potent MSC population from murine bone marrow based on their expression of stem cell antigen-1 (Sca-1) and platelet derived growth factor- alpha (PDGFRα) (PαS cells) using flow cytometry. PαS MSCs have augmented growth potential and robust tri-lineage differentiation compared to plastic adherent cells. They exert potent immunosuppressive effects on proliferating naive CD4+ T cells, which is mediated via the production of nitric oxide (NO). Nevertheless, prolonged culture results in cellular senescence, loss of adipogenic differentiation and reduced immunosuppressive properties. Addition of growth factors to standard media (SM) produced significant genotypic and phenotypic changes. Cells cultured in SM supplemented with basic fibroblast growth factor (bFGF) and platelet derived growth factor-BB (PDGF-BB) were primed towards fat and cartilage, but had reduced immunosuppressive potential. In contrast, cells cultured with transforming growth factor-beta (TGF-β) had reduced tri-lineage potential but potent immunosuppressive properties that endured despite long term culture. I demonstrate using novel tissue engineering techniques that bFGF PαS MSCs generate substantial 3-D cartilage pellets. These data have implications for MSC therapy in humans."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/5551/1/Houlihan14PhD.pdf","http://etheses.bham.ac.uk//id/eprint/5551/2/Decl_IS_Houlihan14PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","School of Immunity and Infection"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/5551/"],"dc:subject":["R Medicine (General)","RC Internal medicine"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Growth factors direct mesenchymal stem cell fate and therapeutic potential"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:28:26Z"}